scholarly journals P348 The efficacy and safety of infliximab therapy in Korean patients with Crohn's diseases: a retrospective, multicenter study

2013 ◽  
Vol 7 ◽  
pp. S149
Author(s):  
C.H. Choi ◽  
K.H. Lee ◽  
S.K. Chang ◽  
W.H. Kim ◽  
Y.H. Kim
Keyword(s):  
Multicenter Study ◽  
Infliximab Therapy ◽  
Efficacy And Safety ◽  
Korean Patients ◽  
Retrospective Multicenter Study ◽  
Crohn’S Diseases

Sa1896 The Efficacy and Safety of Infliximab Therapy in Korean Patients With Crohn's Diseases: A Retrospective, Multicenter Study

2012 ◽  
Vol 142 (5) ◽  
pp. S-353 ◽  
Author(s):  
Chang Hwan Choi ◽  
In-Do Song ◽  
Bong Ki Cha ◽  
Se Kyung Chang ◽  
Young Ho Kim ◽  
...  
Keyword(s):  
Multicenter Study ◽  
Infliximab Therapy ◽  
Efficacy And Safety ◽  
Korean Patients ◽  
Retrospective Multicenter Study ◽  
Crohn’S Diseases

Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients

2016 ◽  
Vol 43 (8) ◽  
pp. 1547-1552 ◽  
Author(s):  
Alexis Régent ◽  
Serge Redeker ◽  
Alban Deroux ◽  
Pierre Kieffer ◽  
Kim Heang Ly ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Side Effects ◽  
Adverse Events ◽  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Multicenter Study ◽  
Efficacy And Safety ◽  
Severe Adverse Events ◽  
Retrospective Multicenter Study

Objective.To report the efficacy and safety of tocilizumab (TCZ) for giant cell arteritis (GCA).Methods.A retrospective multicenter study that included 34 patients receiving TCZ for GCA.Results.TCZ was effective in all but 6 patients, who still had mild symptoms. Mean glucocorticoid dose was tapered. One patient died and 3 patients had to stop TCZ therapy because of severe adverse events. Twenty-three patients stopped treatment; 8 of these experienced relapses after a mean of 3.5 ± 1.3 months.Conclusion.TCZ is effective in GCA. However, side effects occur. Whether this treatment has only a suspensive effect remains to be determined.

Sign in / Sign up

Export Citation Format

Share Document